| Entry |
|
|---|
| Name |
Edaravone (USAN/JP17/INN);
Radicava (TN);
Radicut (TN)
|
|---|
| Formula |
C10H10N2O
|
|---|
| Exact mass |
174.0793
|
|---|
| Mol weight |
174.1992
|
|---|
| Structure |
   |
|---|
| Simcomp |
 |
|---|
| Remark |
| Therapeutic category: | 1190 |
|
|---|
| Efficacy |
Cerebroprotective |
|---|
| Disease |
Amyotrophic lateral sclerosis [DS: H00058] |
|---|
| Comment |
free radical scavenger
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N07 OTHER NERVOUS SYSTEM DRUGS
N07X OTHER NERVOUS SYSTEM DRUGS
N07XX Other nervous system drugs
N07XX14 Edaravone
D01552 Edaravone (USAN/JP17/INN) <JP>
USP drug classification [BR:br08302]
Central Nervous System Agents
Central Nervous System, Other
Edaravone
D01552 Edaravone (USAN/JP17/INN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
119 Miscellaneous
1190 Miscellaneous
D01552 Edaravone (USAN/JP17/INN)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01552 Edaravone
D01552 Edaravone injection
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D01552
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01552
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01552
 |
|---|
| Other DBs |
|
|---|
| LinkDB |
 |
|---|
| KCF data |
ATOM 13
1 N1y N 30.6339 -15.5305
2 C8y C 29.4278 -14.8294
3 C5x C 31.7883 -14.7005
4 N2x N 31.0277 -16.8662
5 C8x C 29.4278 -13.4391
6 C8x C 28.2218 -15.5305
7 C1x C 32.8929 -15.5943
8 O5x O 31.7623 -13.2795
9 C2y C 32.4248 -16.9047
10 C8x C 28.2218 -12.7439
11 C8x C 27.0157 -14.8294
12 C1a C 33.2137 -18.0662
13 C8x C 27.0157 -13.4391
BOND 14
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 2
6 3 7 1
7 3 8 2
8 4 9 2
9 5 10 2
10 6 11 1
11 9 12 1
12 10 13 1
13 7 9 1
14 11 13 2
|
|---|
